This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
doi: 10.1155/2015/189232. Epub 2015 May 28.

Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis

Affiliations
Review

Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis

Ahmad M Yakasai et al. J Trop Med. 2015.

Abstract

Adherence to artemisinin-based combination therapy (ACT) is not clearly defined. This meta-analysis determines the prevalence and predictors of adherence to ACT. Twenty-five studies and six substudies met the inclusion criteria. The prevalence of ACT adherence in the public sector was significantly higher compared to retail sector (76% and 45%, resp., P < 0.0001). However, ACT adherence was similar across different ACT dosing regimens and formulations. In metaregression analysis prevalence estimates of adherence significantly decrease with increasing year of study publication (P = 0.046). Factors found to be significant predictors of ACT adherence were years of education ≥ 7 {odds ratio (OR) (95% CI) = 1.63 (1.05-2.53)}, higher income {2.0 (1.35-2.98)}, fatty food {4.6 (2.49-8.50)}, exact number of pills dispensed {4.09 (1.60-10.7)}, and belief in traditional medication for malaria {0.09 (0.01-0.78)}. The accuracy of pooled estimates could be limited by publication bias, and differing methods and thresholds of assessing adherence. To improve ACT adherence, educational programs to increase awareness and understanding of ACT dosing regimen are interventions urgently needed. Patients and caregivers should be provided with an adequate explanation at the time of prescribing and/or dispensing ACT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for selecting studies for review and meta-analysis.
Figure 2
Figure 2
Forest plot of prevalence of adherence in the public and retail sectors.
Figure 3
Figure 3
Metaregression of ACT adherence estimate by year of study publication.
Figure 4
Figure 4
Sociodemographic predictors of ACT adherence.
Figure 5
Figure 5
Clinical and dispensing-related predictors of ACT adherence.

References

    1. Mutabingwa T. K. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Tropica. 2005;95(3):305–315. doi: 10.1016/j.actatropica.200506009. - DOI - PubMed
    1. Tanzanian National Bureau of Statistics. Household Budget Survey, 2001, http://www.nbs.go.tz/tnada/index.php/ddibrowser/1.
    1. World Health Organization. WHO/CDS/RBM. 2001.35. Geneva, Switzerland: World Health Organization; 2001. Antimalarial drug combination therapy. Report of a WHO technical consultation.
    1. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. The Lancet. 2004;363(9402):9–17. doi: 10.1016/s0140-6736(03)15162-8. - DOI - PubMed
    1. Whegang S. Y., Tahar R., Foumane V. N., et al. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malaria Journal. 2010;9(1, article 56) doi: 10.1186/1475-2875-9-56. - DOI - PMC - PubMed

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /